...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Construction Management and Economics >Development of a benchmarking framework for pharmaceutical capital projects
【24h】

Development of a benchmarking framework for pharmaceutical capital projects

机译：制定制药资本项目的基准框架

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Benchmarking is a proven technique for improving project performance and, as such, is a critical component of any mature project delivery system. Competitive benchmarking requires industry-specific metrics in absolute terms since processes vary by industry, and any metrics used within a single industry must be attuned to its particular processes. A framework is developed for evaluating pharmaceutical capital facility projects using metrics specific to the characteristics of these unique projects. Establishment of the framework made possible the development of a set of industry-specific metrics and a flexible data collection and reporting system for measuring project performance. Preliminary findings from an initial sample of 40 pharmaceutical projects confirm that meaningful industry-specific metrics can be produced for pharmaceutical capital facilities benchmarking. Developing such a framework enables the industry to measure project performance more accurately, get meaningful project performance comparisons, and ultimately establish credible norms for project performance.
机译：基准测试是提高项目绩效的一种行之有效的技术，因此，它是任何成熟项目交付系统的关键组成部分。竞争性基准测试需要绝对的行业特定指标，因为流程会因行业而异，并且单个行业内使用的任何指标都必须调整为其特定流程。开发了一个框架，用于使用针对这些独特项目特征的指标来评估制药资本设施项目。该框架的建立使开发一套特定于行业的度量标准以及用于测量项目绩效的灵活的数据收集和报告系统成为可能。从40个制药项目的初始样本中得出的初步结果证实，可以为制药资本设施基准制定有意义的行业特定指标。开发这样的框架可以使行业更准确地衡量项目绩效，获得有意义的项目绩效比较，并最终建立可靠的项目绩效准则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号